trial

E-cigarettes to Promote Smoking Reduction Among Individuals With Schizophrenia

NCTId NCT02918630
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 7 (actual)
Sponsored by The University of Texas Health Science Center, Houston
Primary completion 2017-08
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
7 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2016-10
Primary completion
2017-08
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Nicotine patchE-cigarette

Sponsors

The University of Texas Health Science Center, HoustonLead Sponsor

Investigators

1
Jin Ho Yoon, PhDPrincipal Investigator

Sites

1 total
Houston, United States

Facts & assertions

4 sourced
Enrollment
7
Phase
NA
Primary Completion Date
2017-08
Status
COMPLETED
relationships
The graph out of here
drug
Nicotine patch
drug
E-cigarette
drug
lead_sponsor
The University of Texas Health Science Center, Houston
company
indication
Schizophrenia
indication
Tobacco Smoking
indication
Vaping
indication
investigator
Jin Ho Yoon, PhD
person